Editor-in-Chief's Column
2024 European Urological Society Annual Meeting: Frontier Explorations and Future Trends in Prostate Cancer Research
Huang Hai, Cheng Bisheng, Huang Jian
Expert Profile
Jian Huang is a professor and doctoral supervisor at Sun Yat-sen University, and the director of the Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University. Chairman of the Urology Branch of the Chinese Medical Association and head of the Oncology Group, Vice President of the Medical Robot Physician Branch of the Chinese Medical Doctor Association, Editor-in-Chief of the Chinese Journal of Urology, Editor-in-Chief of the Chinese Guidelines for the Diagnosis and Treatment of Urological and Andrological Diseases, Deputy Editor-in-Chief of the Chinese Journal of Laparoscopic Urology (Electronic Edition), Deputy Editor-in-Chief of the Journal of Minimally Invasive Urology, International Journal of Urology, Asian Journal of Urology and Member of the editorial board of Journal of Endourology and other journals. His main research interests are minimally invasive urology and urogenital tumors. He is one of the pioneers of laparoscopic technology in urology in mainland China, specializing in difficult laparoscopic surgeries such as total cystectomy, radical prostatectomy, and partial nephrectomy, as well as various urological robotic surgeries, 3D laparoscopic surgeries and single-port laparoscopic surgeries.
Hai Huang is a professor and doctoral supervisor at Sun Yat-sen University. Secretary of the Party Branch, Deputy Director and Chief Physician of the Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University. Outstanding medical talent in Guangdong Province, good doctor of the people, good doctor of Yangcheng, medical research talent. Deputy leader of the Youth Group of the Urology Branch of the Chinese Medical Association, Deputy Head of the Urinary Control Group of the Urology Branch of the Chinese Medical Association, Chairman of the Lower Urinary Tract Disease Committee of the Guangdong Provincial Association of Primary Medicine, Vice Chairman of the Youth Committee of the Urology Branch of the Guangdong Medical Association, and Chief Expert of the Neurogenic Bladder MDT Team of the Initiator of the Urinary Dysfunction Prevention and Rehabilitation Alliance. He has presided over 5 projects of the National Natural Science Foundation of China, 1 key special project of the National Key R&D Program, 2 key international cooperation projects of Guangdong Province, 2 key projects of Guangzhou City, more than 10 projects of the Provincial Natural Science Foundation and the Provincial Science and Technology Project, and led and presided over more than 10 multi-center clinical studies. He has published nearly 100 high-level papers with a total impact factor of 507 points, and has spoken at many international and domestic conferences.
Sweep it for free to download the full article
【Keywords】 prostate tumor; Prostate-specific membrane antigen positron emission tomography (PSMA-PET); biomarkers; nutritional support; Artificial Intelligence (AI); electronic patient-reported outcomes (ePROMs); E-Health
As a major threat to men's health worldwide, prostate cancer continues to attract widespread attention from medical researchers. With the rapid development of medical technology and the deepening of biomedical research, the diagnosis, treatment and management methods of prostate cancer have been continuously innovated, bringing more accurate, efficient and humanized treatment options for patients. The 2024 European Association of Urology (EAU) Annual Meeting brings together experts and scholars in the field of prostate cancer from around the world to discuss the latest research results and the key points of updated treatment guidelines, aiming to provide better diagnosis and treatment options and quality of life for prostate cancer patients. This article summarizes the research frontiers of prostate cancer diagnosis, treatment, and guideline update, which were the focus of the conference.
outline
(Click "Read the original article" at the end of the article to download the full article for free)
1. Controversy and progression of the initial staging of prostate cancer
1. The role and challenges of molecular imaging
2. The role of biomarkers in prediction and treatment decisions
3. Treatment strategies for patients with PSMA-positive M1a
2. Focal treatment of prostate cancer
3. The importance of nutrition in the management of prostate cancer
4. Technological innovation in the treatment of prostate cancer
V. Conclusions and future prospects
The 2024 European Association of Urology (EAU) conference covers several important aspects of prostate cancer research and treatment, from the initial staging controversy of the disease to the latest advances in focal treatment, to the critical role of nutrition in patient management and the contribution of technological innovation to prostate cancer treatment. These discussions reflect the depth and breadth of the field of prostate cancer treatment, while also showing the rapid transformation that the field is undergoing. Precise and personalized treatment of initial staging: Through the application of molecular imaging and biomarkers, the initial staging of prostate cancer becomes more precise, providing patients with a more personalized treatment plan. Development of focal therapy: Focal therapy offers a treatment option that reduces side effects and preserves quality of life, especially for patients with early- and intermediate-low risk prostate cancer. The role of nutrition in disease management: The importance of nutrition and healthy lifestyles is emphasized and is essential to improve the overall health and treatment response of patients. Driven by technological innovation: The application of remote monitoring, artificial intelligence, and big data is changing the way prostate cancer is diagnosed and treated, improving the accuracy and efficiency of treatment.
Future research will continue to explore and deepen these topics, especially in the following areas: (1) Further optimization and personalization of prostate cancer treatment: As our understanding of disease mechanisms and treatment response continues to deepen, future treatments will be more personalized and precise. (2) Innovation and validation of focal treatment technologies: New focal treatment technologies and methods will continue to be developed and tested to improve treatment efficacy and safety. (3) Long-term effects of nutritional interventions: More research will focus on the impact of specific nutritional interventions on the long-term prognosis of prostate cancer, and how to more effectively integrate nutritional strategies into the treatment and recovery process of patients. (4) Further application of technological innovation in treatment: The application of artificial intelligence, machine learning and remote health monitoring technology will be further expanded to provide more support for early diagnosis, treatment monitoring and patient management of prostate cancer. Through these efforts, we look forward to being able to treat prostate cancer more effectively in the future while minimizing the impact on patients' quality of life."
This text is reduced
HUANG Hai , CHENG Bisheng , HUANG Jian.2024 European Urological Society Annual Meeting: Frontier Exploration and Future Trends in Prostate Cancer Research [J/OL].Chinese Journal of Laparoscopic Urology (Electronic Edition), 2024, 18(3): 202-207.
This platform aims to deliver more medical information to healthcare professionals. The content published on this platform should not be used as a substitute for professional medical guidance in any way, nor should it be regarded as diagnosis and treatment advice. If such information is used for purposes other than understanding medical information, the platform does not assume relevant responsibilities. This platform does not mean that it agrees with its descriptions and views on the published content. If copyright issues are involved, please contact us, and we will deal with it as soon as possible.